ICD Firms Urge Delay In MTWA Coverage Decision, Despite Doctors’ Support
This article was originally published in The Gray Sheet
Executive Summary
In a new argument, Medtronic contends that CMS' proposed national decision to cover Microvolt T-Wave Alternans testing may undermine the agency's efforts to cut costs